Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Dermatology|November 11, 2024
Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case seriesTakeya Adachi, Tomoya Matsui, Utako Okata-Karigane, et al.
Japanese Journal of Clinical Oncology|March 24, 2017
Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancerKenta Masuda, Akira Hirasawa, Haruko Irie-Kunitomi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2025
Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancerTetsuya Matsukawa, Tsunenori Ouchida, Taeko Hayakawa, et al.
Journal of Gynecologic Oncology|December 1, 2023
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatmentManabu Seino, Satoru Nagase, Hideki Tokunaga, et al.
Biomedical Reports|December 5, 2019
Erratum: Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)Kiyoko Umene, Kouji Banno, Iori Kisu, et al.
Clinical Medicine Insights. Oncology|October 1, 2025
A Systematic Review of the Application of Artificial Intelligence in Colposcopy: Diagnostic Accuracy for Cervical Intraepithelial Neoplasia and Cervical CancerTakayuki Takahashi, Yusuke Kobayashi, Rieko Sakurai, et al.
Japanese Journal of Clinical Oncology|October 18, 2014
Osteoporosis is less frequent in endometrial cancer survivors with hypertriglyceridemiaAkira Hirasawa, Kazuya Makita, Tomoko Akahane, et al.
Biomedical Reports|March 21, 2014
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumorsKiyoko Umene, Kouji Banno, Iori Kisu, et al.
Gynecologic Oncology|July 17, 2021
ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancerYuka Kuroda, Tatsuyuki Chiyoda, Miho Kawaida, et al.
Pageof 16